About this policy
The comment period for the MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer DL38443 Local Coverage Determination (LCD) began on 09/26/2019 and ended on 11/10/2019. No comments were received from the provider community. The notice period for L38443 begins on 4/30/2020 and it will become effective on 6/14/2020. The title for this LCD changed from “MolDX: Razor 14-Gene Lung Cancer Assay” to “MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer”.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.